Exelixis strives to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future.

Biotechnology

Exelixis

Exelixis' headquarters in Alameda, CA, United States

Michael M. Morrissey

Carol O'Hear

Jeff Nicola

Mandana Asgharnejad

Chris Senner

Dana T. Aftab

Gisela Schwab

Jeffrey J. Hessekiel

Khalid Shah

Nichole Blatner

Jacquelyn Ritchie

Michael Cancilla

Balaji K.

Charles Blazey

Isaac Kennedy

James C Wong

Tony Redmond

Anthony Redmond

Andrew Peters

Christopher J. Senner

P.J. Haley

Susan T. Hubbard

George Poste

Maria C. Freire

Stelios Papadopoulos

Jack L. Wyszomierski

Julie Anne Smith

Robert L. Oliver, Jr.

Tomas J. Heyman

David E. Johnson

Mary C. Beckerle

S. Gail Eckhardt

This department focuses on managing relationships and accounts within the oncology sector, ensuring effective communication and support for oncology services.

Oncology Account Management

This department oversees clinical operations, regulatory affairs, and compliance strategies to ensure efficient and effective medical development processes.

Clinical and Regulatory Operations

The Leadership Team at Exelixis is responsible for guiding the strategic direction of the company, ensuring alignment with its mission to develop innovative cancer therapies. This diverse group of executives oversees key functions such as commercial operations, research and development, regulatory strategy, and corporate affairs, fostering collaboration to enhance patient outcomes and drive growth in the oncology market. Their combined expertise empowers Exelixis to navigate challenges and seize opportunities in the fight against cancer.

Leadership Team

This department conducts scientific research and development to advance knowledge and innovation in various disciplines.

Research Science

This department focuses on the application of statistical methods to analyze and interpret biological data for research and development purposes.

Biostatistics Department

The Scientific and Clinical Research team at Exelixis is dedicated to advancing cancer treatments through rigorous clinical trials and innovative research. This multidisciplinary group collaborates on drug safety, biostatistical analysis, data management, and medical communications, ensuring the successful development of novel therapies. They work closely with various stakeholders to optimize clinical operations and translate scientific insights into actionable strategies, ultimately enhancing patient outcomes.

Scientific and Clinical Research

Exelixis

Org chart

Board & advisors

Teams

Oncology Account Management

Clinical and Regulatory Operations

Leadership Team

Research Science

Biostatistics Department

Scientific and Clinical Research

Offices

Exelixis

Org chart

Board & advisors

Teams

Oncology Account Management

Clinical and Regulatory Operations

Leadership Team

Research Science

Biostatistics Department

Scientific and Clinical Research

Offices

Related companies